IN190699B - - Google Patents

Info

Publication number
IN190699B
IN190699B IN119MU2001A IN190699B IN 190699 B IN190699 B IN 190699B IN 119MU2001 A IN119MU2001 A IN 119MU2001A IN 190699 B IN190699 B IN 190699B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Nitin Bhalachand Dharmadhikari
Ratnesh Harinaraya Shrivastava
Pratibha S Pilgaonkar
Shivanand Premanand Dr Puthli
Suma Girish Menon
Jayant Shrikant Dr Karajgi
Original Assignee
Sun Pharmaceutical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Ind Ltd filed Critical Sun Pharmaceutical Ind Ltd
Priority to IN119MU2001 priority Critical patent/IN190699B/en
Priority to PCT/IN2001/000120 priority patent/WO2002060414A1/en
Priority to US09/891,848 priority patent/US6534090B2/en
Priority to BE2001/0666A priority patent/BE1013713A6/fr
Publication of IN190699B publication Critical patent/IN190699B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN119MU2001 2001-02-02 2001-02-02 IN190699B (en:Method)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IN119MU2001 IN190699B (en:Method) 2001-02-02 2001-02-02
PCT/IN2001/000120 WO2002060414A1 (en) 2001-02-02 2001-06-21 Oral osmotic controlled drug delivery system for a sparingly soluble drug
US09/891,848 US6534090B2 (en) 2001-02-02 2001-06-26 Oral osmotic controlled drug delivery system for a sparingly soluble drug
BE2001/0666A BE1013713A6 (fr) 2001-02-02 2001-10-16 Systeme d'administration orale osmotique controlee pour medicament moderement soluble.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN119MU2001 IN190699B (en:Method) 2001-02-02 2001-02-02

Publications (1)

Publication Number Publication Date
IN190699B true IN190699B (en:Method) 2003-08-16

Family

ID=11097217

Family Applications (1)

Application Number Title Priority Date Filing Date
IN119MU2001 IN190699B (en:Method) 2001-02-02 2001-02-02

Country Status (4)

Country Link
US (1) US6534090B2 (en:Method)
BE (1) BE1013713A6 (en:Method)
IN (1) IN190699B (en:Method)
WO (1) WO2002060414A1 (en:Method)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1227666C (zh) * 1999-01-29 2005-11-16 高超明智公司 小型盘支架和夹持器
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20030175346A1 (en) * 2002-02-01 2003-09-18 Anne Billotte Osmotic delivery system
US6620900B2 (en) * 2002-02-07 2003-09-16 Isp Investments Inc. Proliferous copolymer of vinyl pyrrolidone and vinyl acetate
US20070077301A1 (en) * 2002-12-23 2007-04-05 Meyer Glenn A Venlafaxine osmotic device formulation
US8293799B2 (en) * 2003-12-29 2012-10-23 Osmotica Keresleedelmo és Szolgáltató KFT Osmotic device containing a venlafaxine salt and a salt having an ion in common
AR053986A1 (es) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent Dispositivo osmotico que contiene amantadina y una sal osmotica
WO2006070406A1 (en) * 2004-12-29 2006-07-06 J.B. Chemicals & Pharmaceuticals Ltd Bilayer tablets of oxcarbazepine for controlled delivery and a process of preparation thereof
EP1690540A1 (en) * 2005-02-15 2006-08-16 Neuro3D Composition comprising ocaperidone
US8030260B2 (en) 2005-03-25 2011-10-04 Chemsil Silicones, Inc Pre-shave compositions and methods of using same
US7405186B2 (en) * 2005-03-25 2008-07-29 Chemsil Silicones, Inc. Lubricant compositions, condom products and methods of making same
US20060252745A1 (en) 2005-05-06 2006-11-09 Almeida Jose L D Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
US7855279B2 (en) * 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
US20090099031A1 (en) * 2005-09-27 2009-04-16 Stemmer Willem P Genetic package and uses thereof
US20070191272A1 (en) * 2005-09-27 2007-08-16 Stemmer Willem P Proteinaceous pharmaceuticals and uses thereof
US7846445B2 (en) * 2005-09-27 2010-12-07 Amunix Operating, Inc. Methods for production of unstructured recombinant polymers and uses thereof
CA2634974A1 (en) 2005-12-30 2007-07-12 Zensun (Shanghai) Science & Technology, Ltd. Extended release of neuregulin for improved cardiac function
KR20100058541A (ko) * 2007-08-15 2010-06-03 아뮤닉스 인코포레이티드 생물학적 활성 폴리펩티드의 특성을 변경하기 위한 조성물 및 방법
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
CN102164583B (zh) * 2008-09-25 2013-11-06 巴斯夫欧洲公司 聚醚基和乙烯基单体基共聚物作为包含固体活性成分的剂型用粘合剂的用途
ES2730800T3 (es) 2009-02-03 2019-11-12 Amunix Pharmaceuticals Inc Polipéptidos recombinantes extendidos y composiciones que comprenden los mismos
US20110046060A1 (en) 2009-08-24 2011-02-24 Amunix Operating, Inc., Coagulation factor IX compositions and methods of making and using same
JP5839597B2 (ja) 2009-06-08 2016-01-06 アムニクス オペレーティング インコーポレイテッド グルコース調節ポリペプチド並びにその作成及び使用方法
EP3278813A1 (en) 2009-06-08 2018-02-07 Amunix Operating Inc. Growth hormone polypeptides and methods of making and using same
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
WO2013054178A2 (en) 2011-10-14 2013-04-18 Micro Labs Limited Extended release pharmaceutical compositions containing carmabazepine
EP2822577B1 (en) 2012-02-15 2019-02-06 Bioverativ Therapeutics Inc. Recombinant factor viii proteins
DK2814840T3 (da) 2012-02-15 2020-02-03 Bioverativ Therapeutics Inc Faktor viii-sammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
KR20150040917A (ko) 2012-07-09 2015-04-15 포스모 메드, 잉크 막 매개성 정삼투를 사용하는 장치
US9394327B1 (en) * 2013-03-15 2016-07-19 The Trustees Of California State University Nucleoside crystals, crystal nucleation and growth control with antifreeze proteins
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形
US10548953B2 (en) 2013-08-14 2020-02-04 Bioverativ Therapeutics Inc. Factor VIII-XTEN fusions and uses thereof
TWI741992B (zh) 2015-08-03 2021-10-11 美商百歐維拉提夫治療公司 因子ｉｘ融合蛋白以及其製備及使用方法
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US11191737B2 (en) 2016-05-05 2021-12-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
KR20240069834A (ko) 2016-12-02 2024-05-20 바이오버라티브 테라퓨틱스 인크. 키메라 응고 인자를 사용해 혈우병성 관절증을 치료하는 방법
CN108125922A (zh) * 2018-01-14 2018-06-08 上海安必生制药技术有限公司 一种卡马西平口服缓释制剂及其制备方法
CN112512555A (zh) 2018-05-18 2021-03-16 比奥维拉迪维治疗股份有限公司 治疗血友病a的方法
BR112022026420A2 (pt) 2020-06-25 2023-04-18 Amunix Pharmaceuticals Inc Composições biespecíficas direcionadas por her-2 e métodos para preparar e usar as mesmas
WO2023076281A1 (en) 2021-10-25 2023-05-04 Aquestive Therapeutics, Inc. Oral and nasal compositions and methods of treatment

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4111202A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4553973A (en) 1982-07-12 1985-11-19 Alza Corporation Process for preparing osmotic device
NL8204205A (nl) * 1982-10-29 1984-05-16 Dsm Resins Bv Polyester en de toepassing daarvan in poederlak.
GB2150830B (en) 1983-12-05 1987-08-19 Alza Corp Drug dispenser
US4716031A (en) 1984-03-21 1987-12-29 Alza Corporation Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
US4685918A (en) 1985-02-01 1987-08-11 Merck & Co., Inc. Lipid osmotic pump
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
USRE34990E (en) 1986-08-07 1995-07-04 Ciba-Geigy Corporation Oral therapeutic system having systemic action
ES2039287T3 (es) * 1987-01-14 1993-09-16 Ciba-Geigy Ag Procedimiento para la obtencion de un sistema terapeutico peroral para productos activos dificilmente solubles.
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
US5874418A (en) * 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use

Also Published As

Publication number Publication date
US20030008006A1 (en) 2003-01-09
WO2002060414A1 (en) 2002-08-08
US6534090B2 (en) 2003-03-18
BE1013713A6 (fr) 2002-06-04

Similar Documents

Publication Publication Date Title
BE2022C531I2 (en:Method)
BE2022C547I2 (en:Method)
BE2022C502I2 (en:Method)
BE2017C059I2 (en:Method)
BE2017C055I2 (en:Method)
BE2017C051I2 (en:Method)
BE2007C047I2 (en:Method)
AU2002307149A8 (en:Method)
JP2002004805A5 (en:Method)
IN2004KO00171A (en:Method)
JP2002243000A5 (en:Method)
JP2001349935A5 (en:Method)
IN190699B (en:Method)
BRPI0209186B1 (en:Method)
JP2002011871A5 (en:Method)
BRPI0204884B1 (en:Method)
CH1379220H1 (en:Method)
JP2001318624A5 (en:Method)
BRPI0101486B8 (en:Method)
JP2002009161A5 (en:Method)
HU0202119D0 (en:Method)
BRPI0210463A2 (en:Method)
JP2002165137A5 (en:Method)
AU2000280389A8 (en:Method)
JP2002221820A5 (en:Method)